| Year |
Citation |
Score |
| 2018 |
Melo-Cardenas J, Xu Y, Wei J, Tan C, Kong S, Gao B, Montauti E, Kirsammer G, Licht JD, Yu J, Ji P, Crispino JD, Fang D. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1 dependent mechanism. Blood. PMID 29844011 DOI: 10.1182/Blood-2017-10-811760 |
0.588 |
|
| 2016 |
Kirsammer G, Crispino JD. Signaling a link between interferon and the traits of Down syndrome. Elife. 5. PMID 27599162 DOI: 10.7554/Elife.20196 |
0.537 |
|
| 2016 |
Kirsammer G, Crispino JD. Signaling a link between interferon and the traits of down syndrome: Elevated interferon signaling is a hallmark of down syndrome Elife. 5. DOI: 10.7554/Elife.201960 |
0.537 |
|
| 2016 |
Kirsammer G, Schultz RF, Rastogi R, Gurbuxani S, Crispino J. A PDZ-Binding Motif in DCAF7 Maintains Hematopoietic Homeostasis and Prevents Malignancy in DS-AMKL Blood. 128: 1205-1205. DOI: 10.1182/Blood.V128.22.1205.1205 |
0.598 |
|
| 2015 |
Goldenson B, Kirsammer G, Stankiewicz MJ, Wen QJ, Crispino JD. Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation. Blood. 125: 2141-50. PMID 25670627 DOI: 10.1182/Blood-2014-12-615401 |
0.556 |
|
| 2014 |
Kirsammer G, Strizzi L, Margaryan NV, Gilgur A, Hyser M, Atkinson J, Kirschmann DA, Seftor EA, Hendrix MJ. Nodal signaling promotes a tumorigenic phenotype in human breast cancer. Seminars in Cancer Biology. 29: 40-50. PMID 25073112 DOI: 10.1016/J.Semcancer.2014.07.007 |
0.366 |
|
| 2014 |
Seftor EA, Seftor RE, Weldon DS, Kirsammer GT, Margaryan NV, Gilgur A, Hendrix MJ. Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal. Seminars in Oncology. 41: 259-66. PMID 24787297 DOI: 10.1053/J.Seminoncol.2014.02.001 |
0.372 |
|
| 2012 |
Malinge S, Bliss-Moreau M, Kirsammer G, Diebold L, Chlon T, Gurbuxani S, Crispino JD. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. The Journal of Clinical Investigation. 122: 948-62. PMID 22354171 DOI: 10.1172/Jci60455 |
0.592 |
|
| 2012 |
Hardy KM, Kirschmann DA, Seftor EA, Kirsammer GT, Strizzi L, Hendrix MJ. Abstract 5204: Mechanisms of Notch4-Nodal regulation of the aggressive melanoma phenotype Cancer Research. 72: 5204-5204. DOI: 10.1158/1538-7445.Am2012-5204 |
0.417 |
|
| 2012 |
Kirsammer G, Strizzi L, Gilgur A, Margaryan N, Kirschmann D, Seftor E, Hendrix MJ. Abstract 3353: Nodal signaling mediates the aggressive, tumorigenic phenotype in breast cancer cells Cancer Research. 72: 3353-3353. DOI: 10.1158/1538-7445.Am2012-3353 |
0.358 |
|
| 2011 |
Strizzi L, Hardy KM, Kirsammer GT, Gerami P, Hendrix MJ. Embryonic signaling in melanoma: potential for diagnosis and therapy. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 819-24. PMID 21464823 DOI: 10.1038/Labinvest.2011.63 |
0.427 |
|
| 2010 |
Malinge S, Kirsammer G, Bliss-Moreau M, Chlon TM, Diebold L, Chou ST, Weiss M, Gurbuxani S, Crispino J. Development of a Mouse Model of DS Megakaryoblastic Leukemia and Identification of the Hsa21 Gene DYRK1A as a Prominent Contributor to DS-AMKL Blood. 116: 469-469. DOI: 10.1182/Blood.V116.21.469.469 |
0.614 |
|
| 2008 |
Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, Crispino JD. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood. 111: 767-75. PMID 17901249 DOI: 10.1182/Blood-2007-04-085670 |
0.609 |
|
| Show low-probability matches. |